Business Report: Potential for a mega-deal in the pharmaceutical industry
There’s word Pfizer is chasing AstraZeneca in potential $100 billion deal, 680News senior business editor Mike Eppel explains.
Rogers Media
There’s word Pfizer is chasing AstraZeneca in potential $100 billion deal, 680News senior business editor Mike Eppel explains.